Pre- and postpandemic estimates of 2009 pandemic influenza A(H1N1) seroprotection to inform surveillance-based incidence, by age, during the 2013-2014 epidemic in Canada.
Identifieur interne : 000205 ( Main/Exploration ); précédent : 000204; suivant : 000206Pre- and postpandemic estimates of 2009 pandemic influenza A(H1N1) seroprotection to inform surveillance-based incidence, by age, during the 2013-2014 epidemic in Canada.
Auteurs : Danuta M. Skowronski [Canada] ; Catharine Chambers ; Suzana Sabaiduc [Canada] ; Naveed Z. Janjua [Canada] ; Guiyun Li ; Martin Petric [Canada] ; Mel Krajden [Canada] ; Dale Purych ; Yan Li [Canada] ; Gaston De Serres [Canada]Source :
- The Journal of infectious diseases [ 1537-6613 ] ; 2015.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Anticorps antiviraux (immunologie), Colombie-Britannique (épidémiologie), Enfant (MeSH), Enfant d'âge préscolaire (MeSH), Femelle (MeSH), Grippe humaine (épidémiologie), Humains (MeSH), Incidence (MeSH), Jeune adulte (MeSH), Mâle (MeSH), Saisons (MeSH), Sous-type H1N1 du virus de la grippe A (isolement et purification), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Tests d'inhibition de l'hémagglutination (méthodes), Épidémies (MeSH), Études transversales (MeSH).
- MESH :
- immunologie : Anticorps antiviraux.
- isolement et purification : Sous-type H1N1 du virus de la grippe A.
- méthodes : Tests d'inhibition de l'hémagglutination.
- épidémiologie : Colombie-Britannique, Grippe humaine.
- Adolescent, Adulte, Adulte d'âge moyen, Enfant, Enfant d'âge préscolaire, Femelle, Humains, Incidence, Jeune adulte, Mâle, Saisons, Sujet âgé, Sujet âgé de 80 ans ou plus, Épidémies, Études transversales.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Aged (MeSH), Aged, 80 and over (MeSH), Antibodies, Viral (immunology), British Columbia (epidemiology), Child (MeSH), Child, Preschool (MeSH), Cross-Sectional Studies (MeSH), Epidemics (MeSH), Female (MeSH), Hemagglutination Inhibition Tests (methods), Humans (MeSH), Incidence (MeSH), Influenza A Virus, H1N1 Subtype (isolation & purification), Influenza, Human (epidemiology), Male (MeSH), Middle Aged (MeSH), Seasons (MeSH), Young Adult (MeSH).
- MESH :
- chemical , immunology : Antibodies, Viral.
- geographic , epidemiology : British Columbia.
- epidemiology : Influenza, Human.
- isolation & purification : Influenza A Virus, H1N1 Subtype.
- methods : Hemagglutination Inhibition Tests.
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Cross-Sectional Studies, Epidemics, Female, Humans, Incidence, Male, Middle Aged, Seasons, Young Adult.
Abstract
To understand the epidemic resurgence of influenza due to the 2009 pandemic influenza A(H1N1) strain (A[H1N1]pdm09) during the 2013-2014 influenza season, we compared age-related cross-sectional estimates of seroprotection before the pandemic (during 2009) and after the pandemic (during 2010 and 2013) to subsequent surveillance-based, laboratory-confirmed incidence of influenza due to A(H1N1)pdm09 in British Columbia, Canada. Prepandemic seroprotection was negligible except for very old adults (defined as adults aged ≥ 80 years), among whom 80% had seroprotection. Conversely, postpandemic seroprotection followed a U-shaped distribution, with detection in approximately 35%-45% of working-aged adults but in ≥ 70% of very old adults and young children, excluding children aged <5 years in 2013, among whom seroprotection again decreased to <20%. The incidence was 5-fold higher during 2013-2014, compared with 2010-2011, and was highest among children aged <5 years and working-aged adults, reflecting a mirror image of the age-based seroprotection data.
DOI: 10.1093/infdis/jiu366
PubMed: 24973459
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pre- and postpandemic estimates of 2009 pandemic influenza A(H1N1) seroprotection to inform surveillance-based incidence, by age, during the 2013-2014 epidemic in Canada.</title><author><name sortKey="Skowronski, Danuta M" sort="Skowronski, Danuta M" uniqKey="Skowronski D" first="Danuta M" last="Skowronski">Danuta M. Skowronski</name><affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control University of British Columbia, Vancouver.</nlm:affiliation><country>Canada</country><placeName><settlement type="city">Vancouver</settlement><region type="state">Colombie-Britannique</region></placeName><wicri:orgArea>British Columbia Centre for Disease Control University of British Columbia</wicri:orgArea></affiliation></author><author><name sortKey="Chambers, Catharine" sort="Chambers, Catharine" uniqKey="Chambers C" first="Catharine" last="Chambers">Catharine Chambers</name><affiliation><nlm:affiliation>British Columbia Centre for Disease Control.</nlm:affiliation><wicri:noCountry code="no comma">British Columbia Centre for Disease Control.</wicri:noCountry></affiliation></author><author><name sortKey="Sabaiduc, Suzana" sort="Sabaiduc, Suzana" uniqKey="Sabaiduc S" first="Suzana" last="Sabaiduc">Suzana Sabaiduc</name><affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control University of British Columbia, Vancouver.</nlm:affiliation><country>Canada</country><placeName><settlement type="city">Vancouver</settlement><region type="state">Colombie-Britannique</region></placeName><wicri:orgArea>British Columbia Centre for Disease Control University of British Columbia</wicri:orgArea></affiliation></author><author><name sortKey="Janjua, Naveed Z" sort="Janjua, Naveed Z" uniqKey="Janjua N" first="Naveed Z" last="Janjua">Naveed Z. Janjua</name><affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control University of British Columbia, Vancouver.</nlm:affiliation><country>Canada</country><placeName><settlement type="city">Vancouver</settlement><region type="state">Colombie-Britannique</region></placeName><wicri:orgArea>British Columbia Centre for Disease Control University of British Columbia</wicri:orgArea></affiliation></author><author><name sortKey="Li, Guiyun" sort="Li, Guiyun" uniqKey="Li G" first="Guiyun" last="Li">Guiyun Li</name><affiliation><nlm:affiliation>British Columbia Centre for Disease Control.</nlm:affiliation><wicri:noCountry code="no comma">British Columbia Centre for Disease Control.</wicri:noCountry></affiliation></author><author><name sortKey="Petric, Martin" sort="Petric, Martin" uniqKey="Petric M" first="Martin" last="Petric">Martin Petric</name><affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control University of British Columbia, Vancouver.</nlm:affiliation><country>Canada</country><placeName><settlement type="city">Vancouver</settlement><region type="state">Colombie-Britannique</region></placeName><wicri:orgArea>British Columbia Centre for Disease Control University of British Columbia</wicri:orgArea></affiliation></author><author><name sortKey="Krajden, Mel" sort="Krajden, Mel" uniqKey="Krajden M" first="Mel" last="Krajden">Mel Krajden</name><affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control University of British Columbia, Vancouver.</nlm:affiliation><country>Canada</country><placeName><settlement type="city">Vancouver</settlement><region type="state">Colombie-Britannique</region></placeName><wicri:orgArea>British Columbia Centre for Disease Control University of British Columbia</wicri:orgArea></affiliation></author><author><name sortKey="Purych, Dale" sort="Purych, Dale" uniqKey="Purych D" first="Dale" last="Purych">Dale Purych</name><affiliation><nlm:affiliation>BC Biomedical Laboratories, Surrey.</nlm:affiliation><wicri:noCountry code="subField">Surrey</wicri:noCountry></affiliation></author><author><name sortKey="Li, Yan" sort="Li, Yan" uniqKey="Li Y" first="Yan" last="Li">Yan Li</name><affiliation wicri:level="4"><nlm:affiliation>National Microbiology Laboratory, Public Health Agency of Canada University of Manitoba, Winnipeg.</nlm:affiliation><orgName type="university">Université du Manitoba</orgName><country>Canada</country><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author><author><name sortKey="De Serres, Gaston" sort="De Serres, Gaston" uniqKey="De Serres G" first="Gaston" last="De Serres">Gaston De Serres</name><affiliation wicri:level="1"><nlm:affiliation>Institut National de Santé Publique du Québec Laval University, Quebec, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Institut National de Santé Publique du Québec Laval University, Quebec</wicri:regionArea><wicri:noRegion>Quebec</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:24973459</idno><idno type="pmid">24973459</idno><idno type="doi">10.1093/infdis/jiu366</idno><idno type="wicri:Area/Main/Corpus">000272</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000272</idno><idno type="wicri:Area/Main/Curation">000272</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000272</idno><idno type="wicri:Area/Main/Exploration">000272</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Pre- and postpandemic estimates of 2009 pandemic influenza A(H1N1) seroprotection to inform surveillance-based incidence, by age, during the 2013-2014 epidemic in Canada.</title><author><name sortKey="Skowronski, Danuta M" sort="Skowronski, Danuta M" uniqKey="Skowronski D" first="Danuta M" last="Skowronski">Danuta M. Skowronski</name><affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control University of British Columbia, Vancouver.</nlm:affiliation><country>Canada</country><placeName><settlement type="city">Vancouver</settlement><region type="state">Colombie-Britannique</region></placeName><wicri:orgArea>British Columbia Centre for Disease Control University of British Columbia</wicri:orgArea></affiliation></author><author><name sortKey="Chambers, Catharine" sort="Chambers, Catharine" uniqKey="Chambers C" first="Catharine" last="Chambers">Catharine Chambers</name><affiliation><nlm:affiliation>British Columbia Centre for Disease Control.</nlm:affiliation><wicri:noCountry code="no comma">British Columbia Centre for Disease Control.</wicri:noCountry></affiliation></author><author><name sortKey="Sabaiduc, Suzana" sort="Sabaiduc, Suzana" uniqKey="Sabaiduc S" first="Suzana" last="Sabaiduc">Suzana Sabaiduc</name><affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control University of British Columbia, Vancouver.</nlm:affiliation><country>Canada</country><placeName><settlement type="city">Vancouver</settlement><region type="state">Colombie-Britannique</region></placeName><wicri:orgArea>British Columbia Centre for Disease Control University of British Columbia</wicri:orgArea></affiliation></author><author><name sortKey="Janjua, Naveed Z" sort="Janjua, Naveed Z" uniqKey="Janjua N" first="Naveed Z" last="Janjua">Naveed Z. Janjua</name><affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control University of British Columbia, Vancouver.</nlm:affiliation><country>Canada</country><placeName><settlement type="city">Vancouver</settlement><region type="state">Colombie-Britannique</region></placeName><wicri:orgArea>British Columbia Centre for Disease Control University of British Columbia</wicri:orgArea></affiliation></author><author><name sortKey="Li, Guiyun" sort="Li, Guiyun" uniqKey="Li G" first="Guiyun" last="Li">Guiyun Li</name><affiliation><nlm:affiliation>British Columbia Centre for Disease Control.</nlm:affiliation><wicri:noCountry code="no comma">British Columbia Centre for Disease Control.</wicri:noCountry></affiliation></author><author><name sortKey="Petric, Martin" sort="Petric, Martin" uniqKey="Petric M" first="Martin" last="Petric">Martin Petric</name><affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control University of British Columbia, Vancouver.</nlm:affiliation><country>Canada</country><placeName><settlement type="city">Vancouver</settlement><region type="state">Colombie-Britannique</region></placeName><wicri:orgArea>British Columbia Centre for Disease Control University of British Columbia</wicri:orgArea></affiliation></author><author><name sortKey="Krajden, Mel" sort="Krajden, Mel" uniqKey="Krajden M" first="Mel" last="Krajden">Mel Krajden</name><affiliation wicri:level="3"><nlm:affiliation>British Columbia Centre for Disease Control University of British Columbia, Vancouver.</nlm:affiliation><country>Canada</country><placeName><settlement type="city">Vancouver</settlement><region type="state">Colombie-Britannique</region></placeName><wicri:orgArea>British Columbia Centre for Disease Control University of British Columbia</wicri:orgArea></affiliation></author><author><name sortKey="Purych, Dale" sort="Purych, Dale" uniqKey="Purych D" first="Dale" last="Purych">Dale Purych</name><affiliation><nlm:affiliation>BC Biomedical Laboratories, Surrey.</nlm:affiliation><wicri:noCountry code="subField">Surrey</wicri:noCountry></affiliation></author><author><name sortKey="Li, Yan" sort="Li, Yan" uniqKey="Li Y" first="Yan" last="Li">Yan Li</name><affiliation wicri:level="4"><nlm:affiliation>National Microbiology Laboratory, Public Health Agency of Canada University of Manitoba, Winnipeg.</nlm:affiliation><orgName type="university">Université du Manitoba</orgName><country>Canada</country><placeName><settlement type="city">Winnipeg</settlement><region type="state">Manitoba</region></placeName></affiliation></author><author><name sortKey="De Serres, Gaston" sort="De Serres, Gaston" uniqKey="De Serres G" first="Gaston" last="De Serres">Gaston De Serres</name><affiliation wicri:level="1"><nlm:affiliation>Institut National de Santé Publique du Québec Laval University, Quebec, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Institut National de Santé Publique du Québec Laval University, Quebec</wicri:regionArea><wicri:noRegion>Quebec</wicri:noRegion></affiliation></author></analytic><series><title level="j">The Journal of infectious diseases</title><idno type="eISSN">1537-6613</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Aged, 80 and over (MeSH)</term><term>Antibodies, Viral (immunology)</term><term>British Columbia (epidemiology)</term><term>Child (MeSH)</term><term>Child, Preschool (MeSH)</term><term>Cross-Sectional Studies (MeSH)</term><term>Epidemics (MeSH)</term><term>Female (MeSH)</term><term>Hemagglutination Inhibition Tests (methods)</term><term>Humans (MeSH)</term><term>Incidence (MeSH)</term><term>Influenza A Virus, H1N1 Subtype (isolation & purification)</term><term>Influenza, Human (epidemiology)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Seasons (MeSH)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Anticorps antiviraux (immunologie)</term><term>Colombie-Britannique (épidémiologie)</term><term>Enfant (MeSH)</term><term>Enfant d'âge préscolaire (MeSH)</term><term>Femelle (MeSH)</term><term>Grippe humaine (épidémiologie)</term><term>Humains (MeSH)</term><term>Incidence (MeSH)</term><term>Jeune adulte (MeSH)</term><term>Mâle (MeSH)</term><term>Saisons (MeSH)</term><term>Sous-type H1N1 du virus de la grippe A (isolement et purification)</term><term>Sujet âgé (MeSH)</term><term>Sujet âgé de 80 ans ou plus (MeSH)</term><term>Tests d'inhibition de l'hémagglutination (méthodes)</term><term>Épidémies (MeSH)</term><term>Études transversales (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Viral</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>British Columbia</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticorps antiviraux</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Hemagglutination Inhibition Tests</term></keywords><keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Tests d'inhibition de l'hémagglutination</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Colombie-Britannique</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Child</term><term>Child, Preschool</term><term>Cross-Sectional Studies</term><term>Epidemics</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Middle Aged</term><term>Seasons</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Jeune adulte</term><term>Mâle</term><term>Saisons</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Épidémies</term><term>Études transversales</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To understand the epidemic resurgence of influenza due to the 2009 pandemic influenza A(H1N1) strain (A[H1N1]pdm09) during the 2013-2014 influenza season, we compared age-related cross-sectional estimates of seroprotection before the pandemic (during 2009) and after the pandemic (during 2010 and 2013) to subsequent surveillance-based, laboratory-confirmed incidence of influenza due to A(H1N1)pdm09 in British Columbia, Canada. Prepandemic seroprotection was negligible except for very old adults (defined as adults aged ≥ 80 years), among whom 80% had seroprotection. Conversely, postpandemic seroprotection followed a U-shaped distribution, with detection in approximately 35%-45% of working-aged adults but in ≥ 70% of very old adults and young children, excluding children aged <5 years in 2013, among whom seroprotection again decreased to <20%. The incidence was 5-fold higher during 2013-2014, compared with 2010-2011, and was highest among children aged <5 years and working-aged adults, reflecting a mirror image of the age-based seroprotection data.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24973459</PMID><DateCompleted><Year>2015</Year><Month>03</Month><Day>12</Day></DateCompleted><DateRevised><Year>2014</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1537-6613</ISSN><JournalIssue CitedMedium="Internet"><Volume>211</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>The Journal of infectious diseases</Title><ISOAbbreviation>J. Infect. Dis.</ISOAbbreviation></Journal><ArticleTitle>Pre- and postpandemic estimates of 2009 pandemic influenza A(H1N1) seroprotection to inform surveillance-based incidence, by age, during the 2013-2014 epidemic in Canada.</ArticleTitle><Pagination><MedlinePgn>109-14</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jiu366</ELocationID><Abstract><AbstractText>To understand the epidemic resurgence of influenza due to the 2009 pandemic influenza A(H1N1) strain (A[H1N1]pdm09) during the 2013-2014 influenza season, we compared age-related cross-sectional estimates of seroprotection before the pandemic (during 2009) and after the pandemic (during 2010 and 2013) to subsequent surveillance-based, laboratory-confirmed incidence of influenza due to A(H1N1)pdm09 in British Columbia, Canada. Prepandemic seroprotection was negligible except for very old adults (defined as adults aged ≥ 80 years), among whom 80% had seroprotection. Conversely, postpandemic seroprotection followed a U-shaped distribution, with detection in approximately 35%-45% of working-aged adults but in ≥ 70% of very old adults and young children, excluding children aged <5 years in 2013, among whom seroprotection again decreased to <20%. The incidence was 5-fold higher during 2013-2014, compared with 2010-2011, and was highest among children aged <5 years and working-aged adults, reflecting a mirror image of the age-based seroprotection data.</AbstractText><CopyrightInformation>© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Skowronski</LastName><ForeName>Danuta M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>British Columbia Centre for Disease Control University of British Columbia, Vancouver.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chambers</LastName><ForeName>Catharine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>British Columbia Centre for Disease Control.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabaiduc</LastName><ForeName>Suzana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>British Columbia Centre for Disease Control University of British Columbia, Vancouver.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janjua</LastName><ForeName>Naveed Z</ForeName><Initials>NZ</Initials><AffiliationInfo><Affiliation>British Columbia Centre for Disease Control University of British Columbia, Vancouver.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Guiyun</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>British Columbia Centre for Disease Control.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petric</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>British Columbia Centre for Disease Control University of British Columbia, Vancouver.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krajden</LastName><ForeName>Mel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>British Columbia Centre for Disease Control University of British Columbia, Vancouver.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Purych</LastName><ForeName>Dale</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>BC Biomedical Laboratories, Surrey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Microbiology Laboratory, Public Health Agency of Canada University of Manitoba, Winnipeg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Serres</LastName><ForeName>Gaston</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institut National de Santé Publique du Québec Laval University, Quebec, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Infect Dis</MedlineTA><NlmUniqueID>0413675</NlmUniqueID><ISSNLinking>0022-1899</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001955" MajorTopicYN="N" Type="Geographic">British Columbia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058872" MajorTopicYN="Y">Epidemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006385" MajorTopicYN="N">Hemagglutination Inhibition Tests</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">A(H1N1)pdm09</Keyword><Keyword MajorTopicYN="N">hemagglutination inhibition</Keyword><Keyword MajorTopicYN="N">incidence</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">seroprotection</Keyword><Keyword MajorTopicYN="N">serosurvey</Keyword><Keyword MajorTopicYN="N">surveillance</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24973459</ArticleId><ArticleId IdType="pii">jiu366</ArticleId><ArticleId IdType="doi">10.1093/infdis/jiu366</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country><region><li>Colombie-Britannique</li><li>Manitoba</li></region><settlement><li>Vancouver</li><li>Winnipeg</li></settlement><orgName><li>Université du Manitoba</li></orgName></list><tree><noCountry><name sortKey="Chambers, Catharine" sort="Chambers, Catharine" uniqKey="Chambers C" first="Catharine" last="Chambers">Catharine Chambers</name><name sortKey="Li, Guiyun" sort="Li, Guiyun" uniqKey="Li G" first="Guiyun" last="Li">Guiyun Li</name><name sortKey="Purych, Dale" sort="Purych, Dale" uniqKey="Purych D" first="Dale" last="Purych">Dale Purych</name></noCountry><country name="Canada"><region name="Colombie-Britannique"><name sortKey="Skowronski, Danuta M" sort="Skowronski, Danuta M" uniqKey="Skowronski D" first="Danuta M" last="Skowronski">Danuta M. Skowronski</name></region><name sortKey="De Serres, Gaston" sort="De Serres, Gaston" uniqKey="De Serres G" first="Gaston" last="De Serres">Gaston De Serres</name><name sortKey="Janjua, Naveed Z" sort="Janjua, Naveed Z" uniqKey="Janjua N" first="Naveed Z" last="Janjua">Naveed Z. Janjua</name><name sortKey="Krajden, Mel" sort="Krajden, Mel" uniqKey="Krajden M" first="Mel" last="Krajden">Mel Krajden</name><name sortKey="Li, Yan" sort="Li, Yan" uniqKey="Li Y" first="Yan" last="Li">Yan Li</name><name sortKey="Petric, Martin" sort="Petric, Martin" uniqKey="Petric M" first="Martin" last="Petric">Martin Petric</name><name sortKey="Sabaiduc, Suzana" sort="Sabaiduc, Suzana" uniqKey="Sabaiduc S" first="Suzana" last="Sabaiduc">Suzana Sabaiduc</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeCanadaV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000205 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000205 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeCanadaV4
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24973459
|texte= Pre- and postpandemic estimates of 2009 pandemic influenza A(H1N1) seroprotection to inform surveillance-based incidence, by age, during the 2013-2014 epidemic in Canada.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24973459" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV4
| This area was generated with Dilib version V0.6.35. |  |